Smoking Status [clna]
abciximab [aapp, imft, phsu]
Percutaneous [spco]
coronary revascularisation [topp]
Pooled [cnce]
EPIC [lbpr]
Tobacco use NOS [fndg]
Study [mnob]
Atherosclerotic heart disease NOS [dsyn]
Syndromes, Acute Coronary [dsyn]
Percutaneous Coronary Intervention [topp]
Limited [ftcn]
Tobacco use NOS [fndg]
Increased [qnco]
fibrinogen levels [lbpr]
Thrombin [aapp, enzy, phsu]
Generation [tmco]
Increased Platelet Aggregation [moft]
Ischaemic [ftcn]
Events [evnt]
Percutaneous Coronary Intervention [topp]
Methods [inpr]
Assessed [acty]
smokers [fndg]
Percutaneous Coronary Intervention [topp]
Ischaemic [ftcn]
Events [evnt]
If [qlco]
glycoprotein IIb IIIa receptor [aapp, imft, rcpt]
Blockade [ftcn]
PREVENT [phsu]
Ischaemic [ftcn]
Events [evnt]
Examined [fndg]
smokers [fndg]
nonsmokers [fndg]
Pooled [cnce]
Large [qnco]
placebo-controlled [resa]
Trial [resa]
Glycoprotein IIb/IIIa Antagonist [chvf]
abciximab [aapp, imft, phsu]
Percutaneous Coronary Intervention [topp]
Patients [podg]
smokers [fndg]
Primary Endpoint [irda]
Myocardial Infarction [dsyn]
Urgent [tmco]
Revascularisation [topp]
days [tmco]
Reduced [qlco]
abciximab [aapp, imft, phsu]
Relative Risk [qnco]
reduction [npop]
P NOS [aapp, imft]
smokers [fndg]
Relative Risk [qnco]
reduction [npop]
P NOS [aapp, imft]
nonsmokers [fndg]
treated [topp]
abciximab [aapp, imft, phsu]
months [tmco]
Myocardial Infarction [dsyn]
Urgent [tmco]
Revascularisation [topp]
Reduced [qlco]
Relative Risk [qnco]
reduction [npop]
P NOS [aapp, imft]
smokers [fndg]
Relative Risk [qnco]
reduction [npop]
P NOS [aapp, imft]
nonsmokers [fndg]
baseline [bodm]
Smoking [inbe]
Independent [idcn]
days [tmco]
Odds Ratio [qnco]
P NOS [aapp, imft]
Conclusions [idcn]
thi [euka]
Pooled [cnce]
Percutaneous Coronary Intervention [topp]
smokers [fndg]
Illness Day [idcn]
nonsmokers [fndg]
Group [idcn]
Degree [qlco]
Benefit [qnco]
Platelet [cell]
Inhibition [menp]
abciximab [aapp, imft, phsu]
